Co-Authors
This is a "connection" page, showing publications co-authored by Naim Ata and Osman Celik.
Connection Strength
1.393
-
Convalescent plasma therapy in patients with COVID-19. Transfus Apher Sci. 2021 Feb; 60(1):102955.
Score: 0.226
-
COVID-19 clinical course and blood groups: Turkish population-based study Turk J Med Sci. 2021 08 30; 51(4):1659-1664.
Score: 0.121
-
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Intern Emerg Med. 2022 01; 17(1):135-139.
Score: 0.119
-
Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data. Int J Cancer. 2020 Dec 07.
Score: 0.115
-
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract. 2020 Oct; 26(7):1676-1682.
Score: 0.112
-
Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study. Diabetes Ther. 2021 Nov; 12(11):2857-2870.
Score: 0.060
-
Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity). Exp Clin Endocrinol Diabetes. 2022 Feb; 130(2):115-124.
Score: 0.060
-
Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia). Endocrine. 2021 08; 73(2):261-269.
Score: 0.060
-
The clinical outcomes of COVID-19 infection in patients with a history of thyroid cancer: A nationwide study. Clin Endocrinol (Oxf). 2021 10; 95(4):628-637.
Score: 0.059
-
The prognostic role of cardiac troponin in hospitalized COVID-19 patients. Atherosclerosis. 2021 05; 325:83-88.
Score: 0.059
-
Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia). J Diabetes. 2021 Jul; 13(7):585-595.
Score: 0.059
-
Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul. Diabetes Res Clin Pract. 2021 Apr; 174:108753.
Score: 0.058
-
Older Adults With Coronavirus Disease 2019: A Nationwide Study in Turkey. J Gerontol A Biol Sci Med Sci. 2021 Feb 25; 76(3):e68-e75.
Score: 0.058
-
Development and validation of clinical prediction model to estimate the probability of death in hospitalized patients with COVID-19: Insights from a nationwide database. J Med Virol. 2021 May; 93(5):3015-3022.
Score: 0.058
-
COVID-19 in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2021 04; 56(4):952-955.
Score: 0.057
-
The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19. J Infect. 2020 12; 81(6):944-951.
Score: 0.057
-
The outcome of COVID-19 in patients with hematological malignancy. J Med Virol. 2021 02; 93(2):1099-1104.
Score: 0.056